enGene Therapeutics, Inc. (ENGN)
1.865
-0.08
(-3.87%)
USD |
NASDAQ |
Oct 05, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
enGene Therapeutics Net Income (Quarterly) : -32.50M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -32.50M |
| April 30, 2026 | -30.23M |
| January 31, 2026 | -29.75M |
| October 31, 2025 | -37.88M |
| July 31, 2025 | -28.99M |
| April 30, 2025 | -25.82M |
| January 31, 2025 | -24.62M |
| October 31, 2024 | -15.30M |
| July 31, 2024 | -14.15M |
| April 30, 2024 | -14.98M |
| January 31, 2024 | -10.71M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.7854M |
| July 31, 2023 | -0.0725M |
| June 30, 2023 | -2.708M |
| March 31, 2023 | -0.3522M |
| December 31, 2022 | 0.6199M |
| September 30, 2022 | 0.0727M |
| June 30, 2022 | -0.2583M |
| March 31, 2022 | -0.4035M |
| December 31, 2021 | -0.2147M |
| September 30, 2021 | -0.0107M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 37.41M |
| Medicus Pharma Ltd. | -8.440M |
| Xenon Pharmaceuticals, Inc. | -110.74M |
| Psyence Biomedical Ltd. | -0.7533M |
| Geron Corp. | -16.68M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 32.50M |
| EPS Diluted (Quarterly) | -0.4661 |
| Enterprise Value | -103.12M |
| Earnings Yield | -111.5% |
| Normalized Earnings Yield | -111.27 |